NERVGEN PHARMA CORP (NGEN.CA) Stock Cash Flow
TSX-V:NGEN - TSX Venture Exchange - CA64082X2032 - Common Stock - Currency: CAD
| TTM (2024-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -24.01M | -20.72M | -12.73M | -11.19M | -9.77M | |||
| Depreciation Amortization | 106.61K | 115.12K | 42.62K | 39.65K | 38.22K | |||
| Change In Working Capital | 388.80K | 2.11M | 430.50K | 1.41M | 206.67K | |||
| Interest Paid | 0.00 | 0.00 | 0.00 | 0.00 | N/A | |||
| Taxes Paid | N/A | 0.00 | 0.00 | 0.00 | N/A | |||
| Other non cash items | 7.24M | 708.04K | 3.98M | 3.43M | 1.43M | |||
| OPERATING CASH FLOW | -16.27M | -17.78M | -8.27M | -6.31M | -8.09M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -21.11K | -45.09K | -3.42K | 0.00 | |||
| INVESTING CASH FLOW | N/A | -21.11K | -45.09K | -3.42K | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -100.93K | -75.70K | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 24.19M | 22.85M | 21.28M | 9.02M | 10.74M | |||
| Other Financing Activity | N/A | -129.04K | -1.67M | -1.17M | -900.79K | |||
| FINANCING CASH FLOW | 22.46M | 22.64M | 19.61M | 7.85M | 9.84M | |||
| Exchange Rate Effect | -3.40K | 686.58K | 31.38K | -46.82K | -113.41K | |||
| CHANGE IN CASH | 6.22M | 5.52M | 11.33M | 1.49M | 1.63M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -16.27M | -17.78M | -8.27M | -6.31M | -8.09M | |||
| Capital Expenditure | N/A | -21.11K | -45.09K | -3.42K | 0.00 | |||
| FREE CASH FLOW | -16.27M | -17.81M | -8.31M | -6.31M | -8.09M | |||
All data in CAD